Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2004 Dec;48(12):4907-10.
doi: 10.1128/AAC.48.12.4907-4910.2004.

A subinhibitory concentration of clarithromycin inhibits Mycobacterium avium biofilm formation

Affiliations
Comparative Study

A subinhibitory concentration of clarithromycin inhibits Mycobacterium avium biofilm formation

George Carter et al. Antimicrob Agents Chemother. 2004 Dec.

Abstract

Mycobacterium avium causes disseminated infection in immunosuppressed individuals and lung infection in patients with chronic lung diseases. M. avium forms biofilm in the environment and possibly in human airways. Antibiotics with activity against the bacterium could inhibit biofilm formation. Clarithromycin inhibits biofilm formation but has no activity against established biofilm.

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
Scanning electron micrograph of M. avium 101 biofilm. Bacteria were seeded on a PVC plate (108 bacteria) and allowed to establish biofilm for 14 days at room temperature. Then the wells were washed and dried, and the bottom of the PVC plate was cut with a blade. It was fixed and stained as described previously (4).
FIG. 2.
FIG. 2.
Effect of azithromycin, clarithromycin, and moxifloxacin on the ability of M. avium to form biofilm. Bacteria were seeded onto a PVC plate and incubated with a subinhibitory concentration of azithromycin (8 μg/ml), clarithromycin (1 μg/ml), or moxifloxacin (1 μg/ml) for 14 days. Biofilm establishment was determined as described in the text. *, P < 0.05.
FIG. 3.
FIG. 3.
Ability of clarithromycin to inhibit biofilm formation when added to M. avium at 0, 4, or 7 days after seeding, at a subinhibitory concentration. Biofilm establishment was determined as described in the text. *, P < 0.05.

References

    1. Aksamit, T. R. 2002. Mycobacterium avium complex pulmonary disease in patients with pre-existing lung disease. Clin. Chest Med. 23:643-653. - PubMed
    1. Bermudez, L. E., C. B. Inderlied, P. Kolonoski, M. Petrofsky, P. Aralar, M. Wu, and L. S. Young. 2001. Activity of moxifloxacin by itself and in combination with ethambutol, rifabutin, and azithromycin in vitro and in vivo against Mycobacterium avium. Antimicrob. Agents Chemother. 45:217-222. - PMC - PubMed
    1. Bermudez, L. E., C. B. Inderlied, P. Kolonoski, M. Wu, P. Aralar, and L. S. Young. 2001. Telithromycin is active against Mycobacterium avium in mice despite lacking significant activity in standard in vitro and macrophage assays and is associated with low frequency of resistance during treatment. Antimicrob. Agents Chemother. 45:2210-2214. - PMC - PubMed
    1. Bermudez, L. E., A. Parker, and J. R. Goodman. 1997. Growth within macrophages increases the efficiency of Mycobacterium avium in invading other macrophages by a complement receptor-independent pathway. Infect. Immun. 65:1916-1925. - PMC - PubMed
    1. Bermudez, L. E., M. Petrofsky, P. Kolonoski, and L. S. Young. 1998. Emergence of Mycobacterium avium populations resistant to macrolides during experimental chemotherapy. Antimicrob. Agents Chemother. 42:180-183. - PMC - PubMed

Publication types

MeSH terms